These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24161597)

  • 1. [Obesity and hypertension].
    Simonyi G; Kollár R
    Orv Hetil; 2013 Nov; 154(44):1736-42. PubMed ID: 24161597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects.
    Phillips CL; Cistulli PA
    Minerva Med; 2006 Aug; 97(4):299-312. PubMed ID: 17008835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-associated hypertension: new insights into mechanisms.
    Rahmouni K; Correia ML; Haynes WG; Mark AL
    Hypertension; 2005 Jan; 45(1):9-14. PubMed ID: 15583075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and insulin resistance in resistant hypertension: implications for the kidney.
    Rao A; Pandya V; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):211-7. PubMed ID: 25908470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep apnea, aldosterone, and resistant hypertension.
    Pimenta E; Calhoun DA; Oparil S
    Prog Cardiovasc Dis; 2009; 51(5):371-80. PubMed ID: 19249443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Obesity: a common prime mover of chronic activation of the sympathetic nervous system and the renin-angiotensin system in systemic hypertension?
    Szelényi Z
    J Appl Physiol (1985); 2010 Dec; 109(6):2008-9. PubMed ID: 21188835
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of hypertension and kidney disease in obesity.
    Hall JE; Brands MW; Henegar JR
    Ann N Y Acad Sci; 1999 Nov; 892():91-107. PubMed ID: 10842655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium and obesity in the pathogenesis of hypertension.
    Reisin E
    Am J Hypertens; 1990 Feb; 3(2):164-7. PubMed ID: 2155002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female Mice.
    Huby AC; Otvos L; Belin de Chantemèle EJ
    Hypertension; 2016 May; 67(5):1020-8. PubMed ID: 26953321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep-disordered breathing and resistant hypertension.
    Wang AY
    Semin Nephrol; 2014; 34(5):520-31. PubMed ID: 25416661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heart in obesity-hypertension.
    Morse SA; Bravo PE; Morse MC; Reisin E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):647-58. PubMed ID: 16076275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of endothelial dysfunction in obesity-associated hypertension.
    Lobato NS; Filgueira FP; Akamine EH; Tostes RC; Carvalho MH; Fortes ZB
    Braz J Med Biol Res; 2012 May; 45(5):392-400. PubMed ID: 22488221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of obesity hypertension.
    Hall JE
    Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension.
    Schütten MT; Houben AJ; de Leeuw PW; Stehouwer CD
    Physiology (Bethesda); 2017 May; 32(3):197-209. PubMed ID: 28404736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of adipose tissue for cardiovascular-renal regulation in health and disease.
    Engeli S; Sharma AM
    Horm Metab Res; 2000; 32(11-12):485-99. PubMed ID: 11246814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hypertension in obese patients].
    Comte-Perret S; Giusti V; Wuerzner G
    Rev Med Suisse; 2013 Sep; 9(397):1622, 1624-6. PubMed ID: 24073473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of abnormal renal sodium handling in obesity hypertension.
    Hall JE
    Am J Hypertens; 1997 May; 10(5 Pt 2):49S-55S. PubMed ID: 9160781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adipokines in obesity-associated hypertension.
    Vlasova M; Purhonen AK; Jarvelin MR; Rodilla E; Pascual J; Herzig KH
    Acta Physiol (Oxf); 2010 Oct; 200(2):107-27. PubMed ID: 20653609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, sleep apnea, aldosterone, and hypertension.
    Goodfriend TL
    Curr Hypertens Rep; 2008 Jun; 10(3):222-6. PubMed ID: 18765094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension in obesity.
    Kurukulasuriya LR; Stas S; Lastra G; Manrique C; Sowers JR
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):647-62, ix. PubMed ID: 18775357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.